08/05/22 4:45 PMNasdaq : ANPC managementlow floatAnPac Bio Announces Appointment of New Directors and Co-Chief Executive OfficerAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that effective August 2, 2022, theRHEA-AIneutral
07/18/22 6:39 PMNasdaq : ANPC low floatAnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the CommitteesAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that the Company’s Members approvedRHEA-AIneutral
06/10/22 7:30 AMNasdaq : ANPC low floatAnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital MarketAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that The Nasdaq Stock Market LLCRHEA-AIneutral
05/31/22 5:00 PMNasdaq : ANPC earningslow floatAnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the first quarter ended March 31,RHEA-AIneutral
05/16/22 5:00 PMNasdaq : ANPC earningslow floatAnPac Bio Reports Fiscal Year 2021 Annual Financial ResultsAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its annual financial results for the year ended December 31, 2021.RHEA-AIpositive
05/11/22 7:30 AMNasdaq : ANPC low floatAnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital MarketAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that The Nasdaq Stock Market LLCRHEA-AIneutral
05/06/22 7:30 AMNasdaq : ANPC low floatNasdaq Hearing Panel Grants AnPac Bio’s Request to Transfer Securities from The Nasdaq Global Market to The Nasdaq Capital MarketAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that the Nasdaq Hearings Panel (theRHEA-AIvery positive
04/11/22 7:30 AMNasdaq : ANPC low floatAnPac Bio and New Investor Sign Equity Investment Totaling $15 MillionAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on April 4, 2022, the CompanyRHEA-AIneutral
04/08/22 9:12 PMNasdaq : ANPC managementlow floatAnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board MemberAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that Dr. Aidong Chen has joined theRHEA-AIneutral
04/04/22 7:30 AMNasdaq : ANPC low floatAnPac Bio Filed Request for a Hearing Regarding Continued Listing on NASDAQ, The Hearing was Granted and scheduled for Late AprilAnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on April 1, 2022, the CompanyRHEA-AIneutral